BioScience Health Innovations (BHIC) Other Accumulated Expenses (2021 - 2025)

BioScience Health Innovations (BHIC) has reported Other Accumulated Expenses for 5 consecutive years, with $228298.0 the latest figure, recorded in Q3 2025.

• In Q3 2025, Other Accumulated Expenses rose 559.82% year-over-year to $228298.0; the TTM figure through Sep 2025 stood at $228298.0 (up 559.82% YoY), while the FY2023 annual figure was $87074.0, up 91.98% from the prior year.
• Other Accumulated Expenses improved to $228298.0 in Q3 2025 per BHIC's latest filing, from $47837.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $228298.0 in Q3 2025 and bottomed at $404.0 in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $65806.8 across 5 years, with a median of $46777.5 in 2025.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses plunged 86.68% — and 2025, when it soared 559.82%.
• BioScience Health Innovations' Other Accumulated Expenses stood at $625.0 in 2021, then tumbled by 35.36% to $404.0 in 2022, then soared by 21452.97% to $87074.0 in 2023, then plunged by 60.26% to $34600.0 in 2024, then jumped by 559.82% to $228298.0 in 2025.
• Business Quant data shows BHIC's Other Accumulated Expenses at $228298.0 in Q3 2025, $47837.0 in Q2 2025, and $45718.0 in Q1 2025.